Gene: Slc6a9 (solute carrier family 6 member 9) Rattus norvegicus
Analyze
Symbol:
Slc6a9
Name:
solute carrier family 6 member 9
Description:
Predicted to have glycine transmembrane transporter activity. Predicted to be involved in glycine secretion, neurotransmission and neurotransmitter uptake. Localizes to several cellular components, including hippocampal mossy fiber to CA3 synapse; integral component of synaptic membrane; and integral component of synaptic vesicle membrane. Orthologous to human SLC6A9 (solute carrier family 6 member 9); INTERACTS WITH (+)-schisandrin B; 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane; 2,2',4,4'-Tetrabromodiphenyl ether.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
glycine transporter 1; glycine transporter variant 1a; GLYT-1; GLYT-1b; Glyt1; sodium- and chloride-dependent glycine transporter 1; solute carrier family 6 (neurotransmitter transporter, glycine), member 9
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC6A9 (solute carrier family 6 member 9) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB
Mus musculus (house mouse):
Slc6a9 (solute carrier family 6 (neurotransmitter transporter, glycine), member 9) HGNC
EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, PhylomeDB, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
SLC6A9 (solute carrier family 6 member 9)
Alliance
DIOPT (PANTHER|HGNC|Ensembl Compara|OMA|PhylomeDB|OrthoFinder|InParanoid|OrthoInspector|Hieranoid)
Mus musculus (house mouse):
Slc6a9 (solute carrier family 6 (neurotransmitter transporter, glycine), member 9)
Alliance
DIOPT (PANTHER|Ensembl Compara|OMA|PhylomeDB|OrthoFinder|InParanoid|OrthoInspector|Hieranoid)
Danio rerio (zebrafish):
slc6a9 (solute carrier family 6 member 9)
Alliance
DIOPT (PANTHER|Ensembl Compara|OMA|PhylomeDB|OrthoFinder|InParanoid|OrthoInspector|Hieranoid)
Drosophila melanogaster (fruit fly):
CG1698
Alliance
DIOPT (OMA|PANTHER|Ensembl Compara)
Drosophila melanogaster (fruit fly):
List
Alliance
DIOPT (OMA|PANTHER|Ensembl Compara)
Drosophila melanogaster (fruit fly):
NAAT1
Alliance
DIOPT (OMA|PANTHER|Ensembl Compara)
Drosophila melanogaster (fruit fly):
CG15279
Alliance
DIOPT (OMA|PANTHER|Ensembl Compara)
Drosophila melanogaster (fruit fly):
CG8850
Alliance
DIOPT (PANTHER|OMA|Ensembl Compara)
Drosophila melanogaster (fruit fly):
CG4476
Alliance
DIOPT (OMA|PANTHER|Ensembl Compara)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 5 136,669,674 - 136,703,702 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 136,669,674 - 136,703,697 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 140,458,723 - 140,492,751 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 138,300,869 - 138,334,893 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 5 138,313,795 - 138,339,599 (+) NCBI Celera 5 129,922,904 - 129,957,106 (+) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Annotations - CTD
amphetamine abuse ISO RGD:732096 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17582620
Imported Annotations - MGI
glycine encephalopathy ISS RGD:732097 13592920 OMIM:605899 MouseDO Imported Annotations - OMIM
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE ISO RGD:732096 7240710 OMIM
(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 17alpha-ethynylestradiol increases expression ISO RGD:732097 6480464 Ethinyl Estradiol results in increased expression of SLC6A9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:732097 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:732096 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC6A9 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732097 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732097 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A9 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A9 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732097 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol increases expression ISO RGD:732097 6480464 n-butoxyethanol results in increased expression of SLC6A9 mRNA CTD PMID:19812364 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:732097 6480464 3 more ... CTD PMID:19467301 4-hydroxyphenyl retinamide increases expression ISO RGD:732097 6480464 Fenretinide results in increased expression of SLC6A9 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC6A9 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:732096 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC6A9 mRNA CTD PMID:20147733 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC6A9 mRNA CTD PMID:31881176 adefovir pivoxil decreases expression ISO RGD:732096 6480464 adefovir dipivoxil results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 aflatoxin B1 increases expression ISO RGD:732097 6480464 Aflatoxin B1 results in increased expression of SLC6A9 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:732096 6480464 Aflatoxin B1 results in increased methylation of SLC6A9 intron CTD PMID:30157460 aflatoxin B2 increases methylation ISO RGD:732096 6480464 aflatoxin B2 results in increased methylation of SLC6A9 intron CTD PMID:30157460 amphetamine affects response to substance ISO RGD:732097 6480464 SLC6A9 protein affects the susceptibility to Amphetamine CTD PMID:15159536 arsane affects methylation ISO RGD:732096 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:732096 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:732096 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 benzamide multiple interactions EXP 6480464 benzamide analog binds to and results in decreased activity of SLC6A9 protein CTD PMID:18355687 benzo[a]pyrene increases expression ISO RGD:732097 6480464 Benzo(a)pyrene results in increased expression of SLC6A9 mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:732096 6480464 Benzo(a)pyrene affects the methylation of SLC6A9 intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:732096 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 benzo[a]pyrene decreases expression ISO RGD:732096 6480464 Benzo(a)pyrene results in decreased expression of SLC6A9 mRNA CTD PMID:22316170 bis(2-chloroethyl) sulfide decreases expression ISO RGD:732097 6480464 Mustard Gas results in decreased expression of SLC6A9 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate increases expression ISO RGD:732097 6480464 Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:732097 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:26982218 bisphenol A increases expression ISO RGD:732096 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A9 mRNA CTD PMID:25181051 butan-1-ol multiple interactions ISO RGD:732096 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 cadmium dichloride decreases expression ISO RGD:732096 6480464 Cadmium Chloride results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 cannabidiol increases expression ISO RGD:732097 6480464 Cannabidiol results in increased expression of SLC6A9 mRNA CTD PMID:21542829 carbon nanotube decreases expression ISO RGD:732097 6480464 Nanotubes, Carbon analog results in decreased expression of SLC6A9 mRNA, Nanotubes, Carbon results in decreased expression of SLC6A9 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:732097 6480464 Nanotubes, Carbon analog results in increased expression of SLC6A9 mRNA, Nanotubes, Carbon results in increased expression of SLC6A9 mRNA CTD PMID:25620056 casticin decreases expression ISO RGD:732097 6480464 casticin results in decreased expression of SLC6A9 mRNA CTD PMID:28444820 chloroacetaldehyde decreases expression ISO RGD:732096 6480464 chloroacetaldehyde results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 choline multiple interactions ISO RGD:732097 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 cidofovir anhydrous decreases expression ISO RGD:732096 6480464 Cidofovir results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:732097 6480464 Ciguatoxins affects the expression of SLC6A9 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:732096 6480464 Cisplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 cisplatin multiple interactions ISO RGD:732096 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC6A9 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:732097 6480464 Clobetasol results in increased expression of SLC6A9 mRNA CTD PMID:27462272 clodronic acid decreases expression ISO RGD:732096 6480464 Clodronic Acid results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SLC6A9 mRNA CTD PMID:17602206 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC6A9 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 coumarin increases expression EXP 6480464 coumarin results in increased expression of SLC6A9 mRNA CTD PMID:18480146 cyclosporin A increases expression ISO RGD:732096 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC6A9 mRNA CTD PMID:23640034 , PMID:23914054 dexamethasone decreases expression ISO RGD:732096 6480464 Dexamethasone results in decreased expression of SLC6A9 mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO RGD:732096 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 diazinon increases methylation ISO RGD:732096 6480464 Diazinon results in increased methylation of SLC6A9 gene CTD PMID:22964155 dibenzo[a,l]pyrene multiple interactions ISO RGD:732096 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC6A9 mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 dioxygen multiple interactions ISO RGD:732097 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC6A9 mRNA] CTD PMID:22629407 dioxygen decreases expression ISO RGD:732096 6480464 Oxygen deficiency results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 dioxygen increases expression ISO RGD:732097 6480464 Oxygen deficiency results in increased expression of SLC6A9 mRNA CTD PMID:22629407 disodium selenite increases expression ISO RGD:732096 6480464 Sodium Selenite results in increased expression of SLC6A9 mRNA CTD PMID:24383545 disulfiram multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC6A9 mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:732096 6480464 Doxorubicin results in decreased expression of SLC6A9 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:29391264 endosulfan increases expression ISO RGD:732096 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:30090376 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:732097 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:732096 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 fenofibrate increases expression ISO RGD:732096 6480464 Fenofibrate results in increased expression of SLC6A9 mRNA CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SLC6A9 mRNA CTD PMID:23962444 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC6A9 mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732097 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of SLC6A9 mRNA CTD PMID:26391144 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of SLC6A9 gene CTD PMID:31011160 ibuprofen increases expression ISO RGD:732096 6480464 Ibuprofen results in increased expression of SLC6A9 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:732096 6480464 Ifosfamide results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 L-methionine multiple interactions ISO RGD:732097 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC6A9 mRNA CTD PMID:11578147 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC6A9 mRNA CTD PMID:16507785 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC6A9 mRNA CTD PMID:25596134 , PMID:31324951 methamphetamine increases response to substance ISO RGD:732096 6480464 SLC6A9 gene SNP results in increased susceptibility to Methamphetamine CTD PMID:17582620 methotrexate affects expression ISO RGD:732097 6480464 Methotrexate affects the expression of SLC6A9 mRNA CTD PMID:18502557 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:732097 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:732097 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:732097 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:22776087 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SLC6A9 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 nobiletin increases expression EXP 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 nobiletin increases expression ISO RGD:732096 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC6A9 mRNA CTD PMID:23439660 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 paracetamol affects expression ISO RGD:732097 6480464 Acetaminophen affects the expression of SLC6A9 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:732096 6480464 Acetaminophen results in increased expression of SLC6A9 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:732096 6480464 Acetaminophen results in decreased expression of SLC6A9 mRNA CTD PMID:26690555 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC6A9 mRNA CTD PMID:17077588 , PMID:18198484 pentachlorophenol increases expression ISO RGD:732097 6480464 Pentachlorophenol results in increased expression of SLC6A9 mRNA CTD PMID:23892564 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 phenobarbital multiple interactions ISO RGD:732097 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC6A9 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:732097 6480464 Phenobarbital affects the expression of SLC6A9 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:732097 6480464 Phenobarbital results in increased expression of SLC6A9 mRNA CTD PMID:19482888 phorone affects expression EXP 6480464 phorone affects the expression of SLC6A9 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:732097 6480464 pirinixic acid results in increased expression of SLC6A9 mRNA CTD PMID:18301758 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A9 mRNA CTD PMID:19162173 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC6A9 mRNA CTD PMID:22431067 rifampicin increases expression ISO RGD:732096 6480464 Rifampin results in increased expression of SLC6A9 mRNA CTD PMID:27199754 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC6A9 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:732096 6480464 Rotenone results in decreased expression of SLC6A9 mRNA CTD PMID:29955902 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of SLC6A9 mRNA CTD PMID:15967596 silicon dioxide increases expression ISO RGD:732096 6480464 Silicon Dioxide analog results in increased expression of SLC6A9 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:732096 6480464 Silicon Dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:25351596 sodium arsenite decreases expression ISO RGD:732097 6480464 sodium arsenite results in decreased expression of SLC6A9 mRNA CTD PMID:31170414 sodium arsenite increases expression ISO RGD:732096 6480464 sodium arsenite results in increased expression of SLC6A9 mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:732097 6480464 Sodium Fluoride results in increased expression of SLC6A9 mRNA CTD PMID:27862939 sunitinib increases expression ISO RGD:732096 6480464 Sunitinib results in increased expression of SLC6A9 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:732097 6480464 Tamoxifen results in decreased expression of SLC6A9 mRNA CTD PMID:25123088 tauroursodeoxycholic acid increases expression EXP 6480464 tauroursodeoxycholic acid results in increased expression of SLC6A9 mRNA CTD PMID:15885361 tetrachloroethene increases expression ISO RGD:732097 6480464 Tetrachloroethylene results in increased expression of SLC6A9 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC6A9 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:732096 6480464 Thapsigargin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 titanium dioxide decreases expression ISO RGD:732097 6480464 titanium dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:29264374 toluene affects expression EXP 6480464 Toluene affects the expression of SLC6A9 mRNA CTD PMID:18653662 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SLC6A9 mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732096 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC6A9 mRNA CTD PMID:29024780 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 tunicamycin increases expression ISO RGD:732096 6480464 Tunicamycin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 , PMID:29453283 urethane decreases expression ISO RGD:732096 6480464 Urethane results in decreased expression of SLC6A9 mRNA CTD PMID:28818685 vanadium atom decreases expression ISO RGD:732096 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:732096 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753
Gene-Chemical Interaction Annotations
